Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP

Proceedings of the National Academy of Sciences of the United States of America

Volumn 91, Issue 12, 1994, Pages 5330-5334

  Bang, Y J ^a,c   Pirnia, F ^a   Fang, W G ^a,d   Kang, W K ^a,c   Sartor, O ^a   Whitesell, L ^a   Ha, M J ^a   Tsokos, M ^b   Sheahan, M D ^a   Nguyen, P ^a   Niklinski, W T ^a   Myers, C E ^a   Trepel, J B ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c Seoul National University Hospital   (South Korea)

^d PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

hormone refractory; multipotential; pp60(c src)

Indexed keywords

CYCLIC AMP; CYCLIC NUCLEOTIDE; NUCLEOTIDE DERIVATIVE;

ADVANCED CANCER; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOMA CELL; CELL DIFFERENTIATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA;

ADENOCARCINOMA; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; CHROMOGRANINS; CYCLIC AMP; CYTOPLASM; ENDOCRINE GLANDS; EPITHELIAL CELLS; HUMAN; MALE; NEURONS; PHOSPHOPYRUVATE HYDRATASE; PROSTATIC NEOPLASMS; S100 PROTEINS;

EID: 0028356553     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.91.12.5330     Document Type: Article

References (22)